5 Best-Performing Non-Energy Stocks of 2022
Alpha Metallurgical Resources, Inc. (NYSE:AMR) is a Tennessee-based mining company that produces and sells met and thermal coal in Virginia and West Virginia.
Posts Tagged ‘NASDAQ:GBT’
Top 5 Small-Cap Stocks With Highest Upside Potential
In this article, we will look at the top 5 small-cap stocks with highest upside potential.
Thomas Steyer’s Farallon Capital is Buying These 5 Stocks
In this article, we discuss 5 stocks that Thomas Steyer’s Farallon Capital is buying.
5 Best Small Cap Stocks To Buy for 2022
In this article, we discuss the 5 best small-cap stocks to buy for 2022.
Hedge Funds Are Coming Back To Global Blood Therapeutics Inc (GBT)
The Insider Monkey team has completed processing the quarterly 13F filings for the September quarter submitted by the hedge funds and other money managers included in our extensive...
Hedge Funds Continue Dumping Global Blood Therapeutics Inc (GBT)
At Insider Monkey, we pore over the filings of nearly 866 top investment firms every quarter, a process we have now completed for the latest reporting period.
Is GBT Stock A Buy or Sell?
The latest 13F reporting period has come and gone, and Insider Monkey is again at the forefront when it comes to making use of this gold mine of data.
5 Best Biotech Stocks to Invest In
Below are the 5 best biotech stocks to invest in according to the billionaire biotech hedge fund manager Joe Edelman.
Hedge Funds Have Never Been This Bullish On Global Blood Therapeutics Inc (GBT)
We know that hedge funds generate strong, risk-adjusted returns over the long run, which is why imitating the picks that they are collectively bullish on can be a profitable strategy...
Did Hedge Funds Make The Right Call On Global Blood Therapeutics Inc (GBT) ?
Insider Monkey has processed numerous 13F filings of hedge funds and successful value investors to create an extensive database of hedge fund holdings.
Global Blood Therapeutics Inc (GBT): Hedge Funds In Wait-and-See Mode
Insider Monkey has processed numerous 13F filings of hedge funds and successful value investors to create an extensive database of hedge fund holdings.
Hedge Funds Are Dumping Global Blood Therapeutics Inc (GBT)
We hate to say this but, we told you so.
Hedge Fund Favorites vs. Global Blood Therapeutics Inc (GBT) In 2019
Out of thousands of stocks that are currently traded on the market, it is difficult to identify those that will really generate strong returns.
Did Hedge Funds Drop The Ball On Global Blood Therapeutics Inc (GBT)?
We are still in an overall bull market and many stocks that smart money investors were piling into surged through the end of November.
Hedge Funds Have Never Been More Bullish On Global Blood Therapeutics Inc (GBT)
Out of thousands of stocks that are currently traded on the market, it is difficult to identify those that will really generate strong returns.
Is Global Blood Therapeutics Inc (GBT) A Good Stock To Buy?
Before we spend countless hours researching a company, we'd like to analyze what insiders, hedge funds and billionaire investors think of the stock first.
Did Hedge Funds Drop The Ball On Global Blood Therapeutics Inc (GBT) ?
At Insider Monkey we track the activity of some of the best-performing hedge funds like Appaloosa Management, Baupost, and Tiger Global because we determined that some of the ...
13G Filing: Perceptive Advisors and Global Blood Therapeutics Inc (GBT)
Please follow Perceptive Advisors (if you aren't already doing so) to get real-time email alerts whenever we publish an article about Perceptive Advisors or update its stock holdings...
13G Filing: Point72 Asset Management and Global Blood Therapeutics Inc. (GBT)
Please follow Point72 Asset Management (if you aren't already doing so) to get real-time email alerts whenever we publish an article about Point72 Asset Management or update its...
5 Stocks The Best Performing Hedge Funds Are Piling Into
At Insider Monkey, we track more than 700 of the best hedge funds in the world and have developed various market-beating strategies over the years using the wealth of data we ...
Here’s Our Take On The Global Blood Therapeutics Inc (GBT) Rumors
Global Blood Therapeutics Inc (NASDAQ:GBT) is spiking towards the end of the week on the suggestion that it might be an acquisition target for a big pharma name.
Is Global Blood Therapeutics Inc (GBT) A Good Stock To Buy?
Investing in hedge funds can bring large profits, but it’s not for everybody, since hedge funds are available only for high-net-worth individuals.
Here’s Why Global Blood, Deutsche Bank, PayPal, and Two Other Stocks Are Trending Today
Amid another spate of earnings releases all three main stock indexes are trading lower today. The Dow Jones is down by 0.21%, the S&P 500 is 0.30% in the red, and the NASDAQ...
5 Stocks That Healthcare Fund Deerfield Management Was Buying in Q2
Founded by James E. Flynn in 2000, Deerfield Management has grown to become one of the premier healthcare-focused investment management companies today.
Movers and Shakers in Biotech: Global Blood Therapeutics Inc (GBT) and Eleven Biotherapeutics Inc (EBIO)
It’s the start of a new week in biotech, and a number of potential catalysts promise to inject some volatility into the space going forward.
Here’s What To Watch From Global Blood Therapeutics Inc (GBT)
Global Blood Therapeutics Inc (NASDAQ:GBT) just kicked off a phase IIa trial in its lead sickle cell candidate, GBT440.
Market Defying Stocks: Why Axiall, Connecture, and 3 Other Stocks Are Rising on a Red Day
It's been a volatile day on Wall Street as the markets initially sold off sharply on fears of the consequences of a potential Brexit.
Deerfield Management Discloses 3.66% Stake In Newly Public Company Global Blood Therapeutics Inc. (GBT)
James E. Flynn’s Deerfield Management has filed a Schedule 13G disclosing a 3.66% ownership stake in the newly public company Global Blood Therapeutics Inc.
